Results 101 to 110 of about 24,887 (213)

Can acromegaly be controlled in all cases?

Journal of Neuroendocrinology, Volume 38, Issue 8, August 2026.
Abstract Acromegaly is a rare disease, due in most of the cases to a growth hormone (GH)‐secreting pituitary adenoma (PA), namely neuroendocrine tumour (PitNET). The treatment of patients with acromegaly is multimodal and multi‐step, including surgery, medical therapies, and radiotherapy.
Sabrina Chiloiro, Francesco Padovano Sorrentino, Alessandra Vicari, Antonella Giampietro, Pier Paolo Mattogno, Quintino Giorgio D'Alessandris, Rosalinda Calandrelli, Tommaso Tartaglione, Marco Gessi, Simona Gaudino, Laura De Marinis, Guido Rindi, Francesco Doglietto, Antonio Bianchi, Alfredo Pontecorvi   +14 more
wiley   +1 more source

Differential Pathophysiological Drivers of Susceptibility to Type 2 Diabetes and Metabolic Dysfunction–Associated Steatotic Liver Disease: Ethnic Differences in Insulin Dynamics, Whole‐Body Fat Metabolism, and Organ‐Specific Lipid Deposition

Obesity Reviews, Volume 27, Issue 8, August 2026.
ABSTRACT Introduction This narrative review explores the epidemiological evidence and potential underlying pathophysiological defects underlying the disproportionately greater risk of Type 2 diabetes (T2D) and cardiometabolic disease in people of South Asian and African Caribbean ancestry compared with White Europeans.
Daniel J. Cuthbertson, Martin Whyte, Alex E. Henney, Uazman Alam, Louise Goff, Barbara A. Fielding, A. Margot Umpleby   +6 more
wiley   +1 more source

Octreotide therapy in dumping syndrome: Analysis of long-term results [PDF]

, 2006
BACKGROUND: Octreotide therapy is effective in controlling severe dumping symptoms during short-term follow-up but little is known about long-term results.
Penning, C., Didden, P., Masclee, A.A.M.
core   +1 more source

OCTREOTIDE IN GASTROENTEROLOGY [PDF]

Medical Journal Armed Forces India, 1997
R, Chaudhry, Balwinder, Singh, P, Subhas
openaire   +2 more sources

Prolonged Octreotide Therapy in a Neonate with Recurrent Congenital Chylothorax

Indian Pediatrics Case Reports
Background: Congenital chylothorax (CC) is the most common cause of pleural effusion in neonates. While octreotide is a known therapy for this condition, refractory cases usually require high doses of the drug or surgical intervention.
Madhurima Ganguly, Sk Md Habibullah, Bijan Saha   +2 more
doaj   +1 more source

Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing’s Syndrome

Case Reports in Endocrinology, 2016
A 30-year-old Caucasian man presented with severe Cushing’s syndrome (CS) resulting from ectopic adrenocorticotropin syndrome (EAS) from a metastatic pancreatic neuroendocrine tumor.
Andreas G. Moraitis, Richard J. Auchus
doaj   +1 more source

Presurgical Octreotide Treatment in Acromegaly [PDF]

, 1991
peer reviewedThe aim of this study was to determine the role of octreotide administration in acromegalic patients as a preparation for selective adenomectomy using transsphenoidal route.
Stevenaert, Achille, Kovacs, K., Harris, A. G., Beckers, Albert   +3 more
core   +1 more source

OCTREOTIDE'NİN YENİDOĞAN STREPTOZOTOCIN DİYABETİK SIÇAN BÖBREĞİ VE IGF-1 DÜZEYLERİ ÜZERİNE ETKİLERİ

Cerrahpaşa Medical Journal, 2019
Background and Design.- It has been shown by the studies that somatostatin and its analogues (octreotide) have a useful effect on the treatment of diabetes and its complications. In this study 4 groups of newborn Wistar rats were prepared.
Matem TUNÇDEMİR, Melek ÖZTÜRK
doaj  

Octreotide in children with hypoglycaemia due to sulfonylurea ingestion [PDF]

, 2008
Sulfonylureas are commonly prescribed for type 2 diabetes mellitus; however, overdose or accidental ingestion may result in profound and prolonged hypoglycaemia with permanent neurological sequelae and death.
Rath, Shoshana, Fahy, Rose, Anderson, Kym, Fahy, Rosemary, Roseby, Robert, Bar-Zeev, Naor, Roseby, Rob   +6 more
core   +1 more source

Intracisternal octreotide does not ameliorate orthodromic trigeminovascular nociception [PDF]

, 2000
Octreotide is a long-acting somatostatin analogue that has been effectively used to treat migraine. Octreotide poorly penetrates the blood-brain barrier, but has potential central target sites in the trigeminal nucleus caudalis, which is the primary ...
Meijler, WJ, Ter Horst, GJ, Kemper, RHA, Jeuring, M, Korf, J   +4 more
core   +1 more source